Anti-human immunodeficiency virus-1 constituents of the bark of Poncirus trifoliata.
A total of 36 compounds (1-36) were obtained from the stem bark of Poncirus trifoliata including three new prenylated flavonoids, (-)-5,4'-dihydroxy-7,8-[(3'',4''-cis-dihydroxy-3'',4''-dihydro)-2'',2''-dimethylpyrano]-flavone (1), (-)-5,4'-dihydroxy-7,8-[(3''-hydroxy-4''-one)-2'',2''-dimethylpyrano]-flavone (2), and (-)-5,4'-dihydroxy-7,8-[(cis-3''-hydroxy-4''-ethoxy-3'',4''-dihydro)-2'',2''-dimethylpyrano]-flavone (3). The new structures were elucidated by means of spectroscopic methods. Compounds 1-20 were evaluated for their anti-human immunodeficiency virus-1 (HIV-1) activity, in which 2 showed significant anti-HIV-1 activity with high therapeutic index (TI) of 143.65.